Related Experiment Videos
Treatment of Early Trilogy Valve Aortic Insufficiency With Valve-in-Valve Transcatheter Aortic Valve Replacement
Johan van Nispen1, Michael Massoomi2, Eric Jeng1
1Department of Surgery, Division of Cardiac Surgery, University of Florida, Gainesville, Florida, USA, ufl.edu.
Abstract:
Aortic insufficiency (AI) is the third most common left valvular heart disease. Transcatheter aortic valve replacement (TAVR) is becoming popular in the treatment of AI. The Trilogy Valve (JenaValve Technology, Irvine, California, United States) is in clinical trials. We report here a case of valve-in-valve TAVR with a Sapien S3 Ultra Resilia valve (Edwards Lifesciences Corporation, Irvine, California, United States) for recurrent AI after Trilogy valve placement.
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Venous Thrombosis III: Interprofessional Care
Mitral Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Aneurysm III: Interprofessional Care